GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AdAlta Ltd (ASX:1AD) » Definitions » Net Interest Income (for Banks)

AdAlta (ASX:1AD) Net Interest Income (for Banks)


View and export this data going back to 2016. Start your Free Trial

What is AdAlta Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


AdAlta (ASX:1AD) Business Description

Industry
Traded in Other Exchanges
N/A
Address
2 Park Drive, Unit 15, Bundoora, VIC, AUS, 3083
AdAlta Ltd is engaged in drug discovery and development company developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases, for which current therapies are sub-optimal. Its pipeline includes Fibrosis, and CAR-T cancer therapeutics.